Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Földvári M[au]:

Search results

Items: 1 to 50 of 109

1.

Multipotent stem cell-derived retinal ganglion cells in 3D culture as tools for neurotrophic factor gene delivery system development.

Chen DW, Narsineni L, Foldvari M.

Nanomedicine. 2019 Oct;21:102045. doi: 10.1016/j.nano.2019.102045. Epub 2019 Jun 28.

PMID:
31255791
2.

Synthetic CpG-ODN rapidly enriches immune compartments in neonatal chicks to induce protective immunity against bacterial infections.

Gunawardana T, Ahmed KA, Goonewardene K, Popowich S, Kurukulasuriya S, Karunarathna R, Gupta A, Lockerbie B, Foldvari M, Tikoo SK, Willson P, Gomis S.

Sci Rep. 2019 Jan 23;9(1):341. doi: 10.1038/s41598-018-36588-6.

3.

Tuning optimum transfection of gemini surfactant-phospholipid-DNA nanoparticles by validated theoretical modeling.

Taheri-Araghi S, Chen DW, Kohandel M, Sivaloganathan S, Foldvari M.

Nanoscale. 2019 Jan 17;11(3):1037-1046. doi: 10.1039/c8nr06442c.

PMID:
30569915
4.

Eco-epidemiology of Novel Bartonella Genotypes from Parasitic Flies of Insectivorous Bats.

Sándor AD, Földvári M, Krawczyk AI, Sprong H, Corduneanu A, Barti L, Görföl T, Estók P, Kováts D, Szekeres S, László Z, Hornok S, Földvári G.

Microb Ecol. 2018 Nov;76(4):1076-1088. doi: 10.1007/s00248-018-1195-z. Epub 2018 Apr 29.

PMID:
29705820
5.

Intrapulmonary Delivery of CpG-ODN Microdroplets Provides Protection Against Escherichia coli Septicemia in Neonatal Broiler Chickens.

Goonewardene KB, Popowich S, Gunawardana T, Gupta A, Kurukulasuriya S, Karunarathna R, Chow-Lockerbie B, Ahmed KA, Tikoo SK, Foldvari M, Willson P, Gomis S.

Avian Dis. 2017 Dec;61(4):503-511. doi: 10.1637/11684-060617-Reg.1.

PMID:
29337617
6.

Three-Dimensional Co-Culture Bioassay for Screening of Retinal Gene Delivery Systems.

Chen DW, Pauloff K, Foldvari M.

Methods Mol Biol. 2018;1715:79-88. doi: 10.1007/978-1-4939-7522-8_6.

PMID:
29188507
7.

Veterinary vaccine nanotechnology: pulmonary and nasal delivery in livestock animals.

Calderon-Nieva D, Goonewardene KB, Gomis S, Foldvari M.

Drug Deliv Transl Res. 2017 Aug;7(4):558-570. doi: 10.1007/s13346-017-0400-9. Review.

PMID:
28639138
8.

Parasites of parasites of bats: Laboulbeniales (Fungi: Ascomycota) on bat flies (Diptera: Nycteribiidae) in central Europe.

Haelewaters D, Pfliegler WP, Szentiványi T, Földvári M, Sándor AD, Barti L, Camacho JJ, Gort G, Estók P, Hiller T, Dick CW, Pfister DH.

Parasit Vectors. 2017 Feb 21;10(1):96. doi: 10.1186/s13071-017-2022-y.

9.

Selective nuclear localization of siRNA by metallic versus semiconducting single wall carbon nanotubes in keratinocytes.

Huzil JT, Saliaj E, Ivanova MV, Gharagozloo M, Loureiro MJ, Lamprecht C, Korinek A, Chen DW, Foldvari M.

Future Sci OA. 2015 Nov 1;1(3):FSO17. doi: 10.4155/fso.15.15. eCollection 2015 Nov.

10.

Checklist of host associations of European bat flies (Diptera: Nycteribiidae, Streblidae).

Szentiványi T, Estók P, Földvári M.

Zootaxa. 2016 Dec 5;4205(2):zootaxa.4205.2.1. doi: 10.11646/zootaxa.4205.2.1.

PMID:
27988583
11.
12.

The intricacies of neurotrophic factor therapy for retinal ganglion cell rescue in glaucoma: a case for gene therapy.

Foldvari M, Chen DW.

Neural Regen Res. 2016 Jun;11(6):875-7. doi: 10.4103/1673-5374.184448. Review.

13.

Targeted nanosystems as therapeutic and diagnostic tools: The beautiful voyage of nanomedicine.

Bottini M, Foldvari M.

Nanomedicine. 2016 Feb;12(2):253-4. doi: 10.1016/j.nano.2015.12.358. Epub 2015 Dec 17. No abstract available.

PMID:
26707819
14.

Impact of phospholipids on plasmid packaging and toxicity of gemini nanoparticles.

Dong C, Badea I, Poorghorban M, Verrall R, Foldvari M.

J Mater Chem B. 2015 Dec 7;3(45):8806-8822. Epub 2015 Sep 29.

15.

Non-viral gene therapy: Gains and challenges of non-invasive administration methods.

Foldvari M, Chen DW, Nafissi N, Calderon D, Narsineni L, Rafiee A.

J Control Release. 2016 Oct 28;240:165-190. doi: 10.1016/j.jconrel.2015.12.012. Epub 2015 Dec 11. Review.

PMID:
26686079
16.

Neuroprotective therapies in glaucoma: II. Genetic nanotechnology tools.

Nafissi N, Foldvari M.

Front Neurosci. 2015 Oct 14;9:355. doi: 10.3389/fnins.2015.00355. eCollection 2015. Review.

17.

Delivery system for mefenamic acid based on the nanocarrier layered double hydroxide: Physicochemical characterization and evaluation of anti-inflammatory and antinociceptive potential.

Cunha VR, Guilherme VA, de Paula E, de Araujo DR, Silva RO, Medeiros JV, Leite JR, Petersen PA, Foldvari M, Petrilli HM, Constantino VR.

Mater Sci Eng C Mater Biol Appl. 2016 Jan 1;58:629-38. doi: 10.1016/j.msec.2015.08.037. Epub 2015 Sep 1.

PMID:
26478354
18.

A flow cytometric approach to study the mechanism of gene delivery to cells by gemini-lipid nanoparticles: an implication for cell membrane nanoporation.

Gharagozloo M, Rafiee A, Chen DW, Foldvari M.

J Nanobiotechnology. 2015 Sep 29;13:62. doi: 10.1186/s12951-015-0125-1.

19.

Neuroprotective therapies in glaucoma: I. Neurotrophic factor delivery.

Nafissi N, Foldvari M.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2016 Mar-Apr;8(2):240-54. doi: 10.1002/wnan.1361. Epub 2015 Aug 26. Review.

PMID:
26306832
20.

Protection of Neonatal Broiler Chickens Following in ovo Delivery of Oligodeoxynucleotides Containing CpG Motifs (CpG-ODN) Formulated with Carbon Nanotubes or Liposomes.

Gunawardana T, Foldvari M, Zachar T, Popowich S, Chow-Lockerbie B, Ivanova MV, Tikoo S, Kurukulasuriya S, Willson P, Gomis S.

Avian Dis. 2015 Mar;59(1):31-7.

PMID:
26292531
21.

Observations of membrane fusion in a liposome dispersion: the missing fusion intermediate?

Foldvari M.

Version 2. F1000Res. 2015 Jan 8 [revised 2015 Jan 1];4:4. doi: 10.12688/f1000research.6003.2. eCollection 2015.

22.

Vertical transmission of Bartonella schoenbuchensis in Lipoptena cervi.

de Bruin A, van Leeuwen AD, Jahfari S, Takken W, Földvári M, Dremmel L, Sprong H, Földvári G.

Parasit Vectors. 2015 Mar 21;8:176. doi: 10.1186/s13071-015-0764-y.

23.

Fauna europaea: Diptera - brachycera.

Pape T, Beuk P, Pont AC, Shatalkin AI, Ozerov AL, Woźnica AJ, Merz B, Bystrowski C, Raper C, Bergström C, Kehlmaier C, Clements DK, Greathead D, Kameneva EP, Nartshuk E, Petersen FT, Weber G, Bächli G, Geller-Grimm F, Van de Weyer G, Tschorsnig HP, de Jong H, van Zuijlen JW, Vaňhara J, Roháček J, Ziegler J, Majer J, Hůrka K, Holston K, Rognes K, Greve-Jensen L, Munari L, de Meyer M, Pollet M, Speight MC, Ebejer MJ, Martinez M, Carles-Tolrá M, Földvári M, Chvála M, Barták M, Evenhuis NL, Chandler PJ, Cerretti P, Meier R, Rozkosny R, Prescher S, Gaimari SD, Zatwarnicki T, Zeegers T, Dikow T, Korneyev VA, Richter VA, Michelsen V, Tanasijtshuk VN, Mathis WN, Hubenov Z, de Jong Y.

Biodivers Data J. 2015 Feb 20;(3):e4187. doi: 10.3897/BDJ.3.e4187. eCollection 2015.

24.

Therapeutic applications of nanomedicine in autoimmune diseases: from immunosuppression to tolerance induction.

Gharagozloo M, Majewski S, Foldvari M.

Nanomedicine. 2015 May;11(4):1003-18. doi: 10.1016/j.nano.2014.12.003. Epub 2015 Jan 14. Review.

PMID:
25596076
25.

Noninvasive ocular drug delivery: potential transcorneal and other alternative delivery routes for therapeutic molecules in glaucoma.

Foldvari M.

J Glaucoma. 2014 Oct-Nov;23(8 Suppl 1):S80-2. doi: 10.1097/IJG.0000000000000122. Review.

PMID:
25275915
26.

Preclinical development and ocular biodistribution of gemini-DNA nanoparticles after intravitreal and topical administration: towards non-invasive glaucoma gene therapy.

Alqawlaq S, Sivak JM, Huzil JT, Ivanova MV, Flanagan JG, Beazely MA, Foldvari M.

Nanomedicine. 2014 Nov;10(8):1637-47. doi: 10.1016/j.nano.2014.05.010. Epub 2014 Jun 4.

PMID:
24905400
27.

DNA ministrings: highly safe and effective gene delivery vectors.

Nafissi N, Alqawlaq S, Lee EA, Foldvari M, Spagnuolo PA, Slavcev RA.

Mol Ther Nucleic Acids. 2014 May 27;3:e165. doi: 10.1038/mtna.2014.16.

28.

The 4th Annual Meeting of the American Society for Nanomedicine.

Gendelman HE, Balogh LP, Bawa R, Bradbury M, Chang EH, Chiu W, Farokhzad O, Foldvari M, Lanza G, Wang K.

J Neuroimmune Pharmacol. 2014 Mar;9 Suppl 1:S1-3. doi: 10.1007/s11481-014-9526-4.

PMID:
24550132
29.

Male eyespan size is associated with meiotic drive in wild stalk-eyed flies (Teleopsis dalmanni).

Cotton AJ, Földvári M, Cotton S, Pomiankowski A.

Heredity (Edinb). 2014 Apr;112(4):363-9. doi: 10.1038/hdy.2013.131. Epub 2014 Jan 8.

30.

Effect of chemical permeation enhancers on stratum corneum barrier lipid organizational structure and interferon alpha permeability.

Moghadam SH, Saliaj E, Wettig SD, Dong C, Ivanova MV, Huzil JT, Foldvari M.

Mol Pharm. 2013 Jun 3;10(6):2248-60. doi: 10.1021/mp300441c. Epub 2013 May 2.

PMID:
23587061
31.

In vivo sustained dermal delivery and pharmacokinetics of interferon alpha in biphasic vesicles after topical application.

King M, Kumar P, Michel D, Batta R, Foldvari M.

Eur J Pharm Biopharm. 2013 Aug;84(3):532-9. doi: 10.1016/j.ejpb.2013.01.014. Epub 2013 Mar 14.

PMID:
23500117
32.

Needle-free gene delivery through the skin: an overview of recent strategies.

Elsabahy M, Foldvari M.

Curr Pharm Des. 2013;19(41):7301-15. Review.

PMID:
23489207
33.

Postmenopausal effects of resistance training on muscle damage and mitochondria.

Manfredi TG, Monteiro MA, Lamont LS, Singh MF, Foldvari M, White S, Cosmas AC, Urso ML.

J Strength Cond Res. 2013 Feb;27(2):556-61. doi: 10.1519/JSC.0b013e318277a1e4.

34.
35.

Challenges in neuroprotective nanomedicine development: progress towards noninvasive gene therapy of glaucoma.

Alqawlaq S, Huzil JT, Ivanova MV, Foldvari M.

Nanomedicine (Lond). 2012 Jul;7(7):1067-83. doi: 10.2217/nnm.12.69. Review.

PMID:
22846092
36.

Pharmaceutical characterization of solid and dispersed carbon nanotubes as nanoexcipients.

Ivanova MV, Lamprecht C, Loureiro MJ, Huzil JT, Foldvari M.

Int J Nanomedicine. 2012;7:403-15. doi: 10.2147/IJN.S27442. Epub 2012 Jan 25.

37.

HPV infections: can they be eradicated using nanotechnology?

Foldvari M.

Nanomedicine. 2012 Feb;8(2):131-5. doi: 10.1016/j.nano.2011.11.006. Epub 2011 Nov 17. Review.

PMID:
22101106
38.

Effect of topical interferon-γ gene therapy using gemini nanoparticles on pathophysiological markers of cutaneous scleroderma in Tsk/+ mice.

Badea I, Virtanen C, Verrall RE, Rosenberg A, Foldvari M.

Gene Ther. 2012 Oct;19(10):978-87. doi: 10.1038/gt.2011.159. Epub 2011 Nov 10.

PMID:
22071972
39.

Drug delivery through the skin: molecular simulations of barrier lipids to design more effective noninvasive dermal and transdermal delivery systems for small molecules, biologics, and cosmetics.

Torin Huzil J, Sivaloganathan S, Kohandel M, Foldvari M.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2011 Sep-Oct;3(5):449-462. doi: 10.1002/wnan.147. Epub 2011 May 18. Review.

PMID:
21595050
40.

Biphasic vesicles: a novel topical drug delivery system.

Foldvari M.

J Biomed Nanotechnol. 2010 Oct;6(5):543-57. Review.

PMID:
21329047
41.

Nanotechnology enables superior medical therapies.

Foldvari M, Elsabahy M.

Curr Drug Deliv. 2011 May;8(3):225-6. No abstract available.

PMID:
21291383
42.

Non-viral nucleic acid delivery: key challenges and future directions.

Elsabahy M, Nazarali A, Foldvari M.

Curr Drug Deliv. 2011 May;8(3):235-44. Review.

PMID:
21291381
43.

Amino acid-substituted gemini surfactant-based nanoparticles as safe and versatile gene delivery agents.

Singh J, Yang P, Michel D, Verrall RE, Foldvari M, Badea I.

Curr Drug Deliv. 2011 May;8(3):299-306.

PMID:
21291379
44.

Biphasic vesicles for topical delivery of interferon alpha in human volunteers and treatment of patients with human papillomavirus infections.

Foldvari M, Badea I, Kumar P, Wettig S, Batta R, King MJ, He Z, Yeboah E, Gaspar K, Hull P, Shear NH.

Curr Drug Deliv. 2011 May;8(3):307-19.

PMID:
21291377
45.

Advancing nonviral gene delivery: lipid- and surfactant-based nanoparticle design strategies.

Donkuru M, Badea I, Wettig S, Verrall R, Elsabahy M, Foldvari M.

Nanomedicine (Lond). 2010 Sep;5(7):1103-27. doi: 10.2217/nnm.10.80. Review.

PMID:
20874024
46.

Enhanced gene expression in epithelial cells transfected with amino acid-substituted gemini nanoparticles.

Yang P, Singh J, Wettig S, Foldvari M, Verrall RE, Badea I.

Eur J Pharm Biopharm. 2010 Aug;75(3):311-20. doi: 10.1016/j.ejpb.2010.04.007. Epub 2010 Apr 22.

PMID:
20417276
47.

Topical delivery of interferon alpha by biphasic vesicles: evidence for a novel nanopathway across the stratum corneum.

Foldvari M, Badea I, Wettig S, Baboolal D, Kumar P, Creagh AL, Haynes CA.

Mol Pharm. 2010 Jun 7;7(3):751-62. doi: 10.1021/mp900283x.

PMID:
20349952
48.

Enhancement of immunoprotective effect of CpG-ODN by formulation with polyphosphazenes against E. coli septicemia in neonatal chickens.

Taghavi A, Allan B, Mutwiri G, Foldvari M, Van Kessel A, Willson P, Babiuk L, Potter A, Gomis S.

Curr Drug Deliv. 2009 Jan;6(1):76-82.

PMID:
19418959
49.

Pathogenesis and therapeutic approaches for improved topical treatment in localized scleroderma and systemic sclerosis.

Badea I, Taylor M, Rosenberg A, Foldvari M.

Rheumatology (Oxford). 2009 Mar;48(3):213-21. doi: 10.1093/rheumatology/ken405. Epub 2008 Nov 20. Review.

PMID:
19022832
50.

Carbon nanotubes as functional excipients for nanomedicines: I. Pharmaceutical properties.

Foldvari M, Bagonluri M.

Nanomedicine. 2008 Sep;4(3):173-82. doi: 10.1016/j.nano.2008.04.002. Epub 2008 Jun 11. Review.

PMID:
18550451

Supplemental Content

Loading ...
Support Center